Element Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Element Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-46,580	Closed	-$4.7M	–	1000
2018 Q4	$4.7M	Buy	46,580 +43,876	+1,623%	+$4.55M	0.13%	124
2018 Q3	$342K	Buy	2,704 +125	+5%	+$13.2K	0.01%	541
2018 Q2	$216K	Buy	+2,579	New	+$189K	0.01%	686
2016 Q3	–	Sell	-95,512	Closed	-$13.6M	–	195
2016 Q2	$13.6M	Buy	+95,512	New	+$13.9M	2.06%	11

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Element Capital Management's ICPT Position: Q1 2019 in Review

Element Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 46,580 shares — an estimated $4.7M sold.

Element Capital Management first reported a position in ICPT in Q2 2016 and held it in 4 quarters. The position peaked at $13.6M in Q2 2016. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

Element Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Element Capital Management sold 46,580 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $4.7M.
Element Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2016 and held it in 4 quarters.
Element Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $13.6M in Q2 2016.
202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on Element Capital Management's 13F filing for Q1 2019, filed 13 May 2019.